search
Back to results

Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality (OPTI-AGED)

Primary Purpose

Coronary; Ischemic, Arrhythmias, Cardiac, Heart Failure

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
OPTI-AGED
Usual Care
Sponsored by
Centre Hospitalier Universitaire de Saint Etienne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Coronary; Ischemic

Eligibility Criteria

75 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All adult patients aged 75 years and over,
  • presenting at least one of the following comorbidities: ischemic coronary disease; cardiac arrhythmia; congestive heart failure; peripheral vascular disease; dementia; stroke; chronic obstructive pulmonary disease; chronic respiratory failure; chronic alcohol abuse; active cancer; diabetes; chronic renal failure A comorbidity index will be measured by using the modified Charlson Comorbidity Index
  • undergoing elective and emergency surgeries including : femoral head fracture, major intraperitoneal abdominal surgery lasting > 90 min (excluding elective cholecystectomy, abdominal wall surgery), vascular surgery (excluding venous surgery and fistula creation)
  • Patient's or patient's relative signed consent form
  • Affiliation to French social assurance system

Exclusion Criteria:

  • Acute heart failure and acute coronary syndrome
  • Acute respiratory failure, pneumonia
  • Septic shock
  • Delirium
  • Acute stroke
  • Evolutive neuromuscular disorder
  • Thoracic surgery, combined abdominal and thoracic surgery
  • Surgery performed under exclusive regional anesthesia
  • Patients under tutorship or curatorship
  • Refusal to participate

Sites / Locations

  • CHU Amiens - Picardie
  • CHU CAEN
  • Chu Clermont-Ferrand
  • Chu Dijon
  • Médipôle Lyon - Villeurbanne
  • Chu Grenoble
  • CHRU Lille - Salengro
  • CHU LILLE - Huriez
  • CHU LYON
  • Lyon Sud - CHU
  • Chu Marseille La Timone
  • Chu Marseille Nord
  • Chu Montpellier
  • Chu Nancy
  • CHU de Nantes
  • CHU NICE
  • Chu Nimes
  • Ch Paris Beaujon
  • Ch Paris Bichat
  • Ch Paris Pitie Salpetriere
  • Ch Paris Saint Antoine
  • Ch Saint Louis-Lariboisiere
  • Chu Poitiers
  • Chu Rennes
  • Chu Rouen
  • Chu Saint Etienne
  • Hopital Central Strasbourg
  • Hopital Hautepierre Strasbourg
  • Chu Toulouse

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Experimental group : OPTI-AGED

Control Group :

Arm Description

The OPTI-AGED group will receive a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia.

The control group will not benefit from the OPTI-AGED intervention but patients will receive the usual care.

Outcomes

Primary Outcome Measures

Incidence of a composite of mortality or major postoperative morbidity.
One or more of major postoperative complications : acute kidney injury (defined by Kidney disease : improving Global Outcomes (KDIGO) stage 1 or higher), acute myocardial infarction, heart failure, stroke, development of sepsisand septic shock, acute respiratory failure requiring non-invasive ventilation or intubation, delirium) will be reported in the source folder of the patients, and the mortality will be also focused. The goal of this study is to decrease this incidence.

Secondary Outcome Measures

Full Information

First Posted
January 22, 2016
Last Updated
August 25, 2021
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Ministry of Health, France
search

1. Study Identification

Unique Protocol Identification Number
NCT02668250
Brief Title
Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality
Acronym
OPTI-AGED
Official Title
The OPTI-AGED Study : Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality in Elderly Patients. A Randomized, Multicentre, Prospective Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
February 3, 2017 (Actual)
Primary Completion Date
February 5, 2020 (Actual)
Study Completion Date
March 16, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Ministry of Health, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
With the increasing aging population demographics and life expectancies, the number of very elderly patients undergoing surgery is rising. Elderly patients constitute an increasingly large proportion of the high-risk surgical group. Cardiac complications and postoperative pulmonary complications are equally prevalent and contribute similarly to morbidity, mortality, and length of hospital stay. Specific optimization strategy of general anesthesia has been tested in high-risk patients undergoing major surgery to improve outcomes. Our hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly undergoing high risk surgery.
Detailed Description
The population is expanding and aging. With the increasing aging population demographics and life expectancies, the number of very elderly patients (age ≥ 75) undergoing surgery is rising. Elderly patients constitute an increasingly large proportion of the high-risk surgical group. In 2010, patients aged 75 yrs and over represented only 2.1% of patients undergoing high risk surgery in France (PMSI database), but concentrated 27% of in-hospital deaths. Cardiac complications and postoperative pulmonary complications are equally prevalent and contribute similarly to morbidity, mortality, and length of hospital stay. Specific optimization strategy of general anesthesia has been tested in high-risk patients undergoing major surgery to improve outcomes. Meta-analyses have demonstrated that goal directed hemodynamic therapy significantly reduced mortality and surgical complications in high-risk patients. A lung-protective ventilation strategy in high-risk patients undergoing major abdominal surgery was associated with improved clinical outcome. Retrospective studies indicated that a combination of excessive depth of anesthesia, hypotension and low anesthesia requirement resulted in increased mortality. These approaches of peroperative care remain discussed in the literature and have also to be incorporated in the common clinical practice. Moreover, few of these reviews performed a sensitive analysis in the elderly. Whether a multi-parametric optimization strategy of anesthesia including several specific interventions will impact the short-term postoperative major morbidity and mortality in elderly is not known. The addition of depth of anesthesia monitoring to hemodynamic monitoring and goal directed hemodynamic therapy may improve tissue perfusion by reducing hemodynamic side effects of anesthetic agents, particularly in elderly where the therapeutic window of these agents is reduced. The effects of low protective ventilation may also by additive to the previous measures by reducing the perioperative build-up of oxygen debt. Our hypothesis is that a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia may improve short- and long- term outcome in elderly undergoing high risk surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary; Ischemic, Arrhythmias, Cardiac, Heart Failure, Peripheral Vascular Diseases, Dementia, Stroke, Pulmonary Disease, Chronic Obstructive, Respiratory Insufficiency, Alcoholism, Cancer, Diabetes, Renal Insufficiency

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2495 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental group : OPTI-AGED
Arm Type
Experimental
Arm Description
The OPTI-AGED group will receive a combined optimization strategy of anesthesia concerning hemodynamic, ventilation, and depth of anesthesia.
Arm Title
Control Group :
Arm Type
Active Comparator
Arm Description
The control group will not benefit from the OPTI-AGED intervention but patients will receive the usual care.
Intervention Type
Procedure
Intervention Name(s)
OPTI-AGED
Intervention Description
OPTI-AGED is composed of a multi-parametric optimization strategy.
Intervention Type
Procedure
Intervention Name(s)
Usual Care
Intervention Description
Patients receive the usual care.
Primary Outcome Measure Information:
Title
Incidence of a composite of mortality or major postoperative morbidity.
Description
One or more of major postoperative complications : acute kidney injury (defined by Kidney disease : improving Global Outcomes (KDIGO) stage 1 or higher), acute myocardial infarction, heart failure, stroke, development of sepsisand septic shock, acute respiratory failure requiring non-invasive ventilation or intubation, delirium) will be reported in the source folder of the patients, and the mortality will be also focused. The goal of this study is to decrease this incidence.
Time Frame
Day 30

10. Eligibility

Sex
All
Minimum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All adult patients aged 75 years and over, presenting at least one of the following comorbidities: ischemic coronary disease; cardiac arrhythmia; congestive heart failure; peripheral vascular disease; dementia; stroke; chronic obstructive pulmonary disease; chronic respiratory failure; chronic alcohol abuse; active cancer; diabetes; chronic renal failure A comorbidity index will be measured by using the modified Charlson Comorbidity Index undergoing elective and emergency surgeries including : femoral head fracture, major intraperitoneal abdominal surgery lasting > 90 min (excluding elective cholecystectomy, abdominal wall surgery), vascular surgery (excluding venous surgery and fistula creation) Patient's or patient's relative signed consent form Affiliation to French social assurance system Exclusion Criteria: Acute heart failure and acute coronary syndrome Acute respiratory failure, pneumonia Septic shock Delirium Acute stroke Evolutive neuromuscular disorder Thoracic surgery, combined abdominal and thoracic surgery Surgery performed under exclusive regional anesthesia Patients under tutorship or curatorship Refusal to participate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
MOLLIEX Serge, MD
Organizational Affiliation
CHU SAINT ETIENNE
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Amiens - Picardie
City
Amiens
Country
France
Facility Name
CHU CAEN
City
Caen
Country
France
Facility Name
Chu Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France
Facility Name
Chu Dijon
City
Dijon
ZIP/Postal Code
21079
Country
France
Facility Name
Médipôle Lyon - Villeurbanne
City
Décines-Charpieu
Country
France
Facility Name
Chu Grenoble
City
Grenoble 9
ZIP/Postal Code
38043
Country
France
Facility Name
CHRU Lille - Salengro
City
Lille
ZIP/Postal Code
59000
Country
France
Facility Name
CHU LILLE - Huriez
City
Lille
ZIP/Postal Code
59037
Country
France
Facility Name
CHU LYON
City
Lyon
Country
France
Facility Name
Lyon Sud - CHU
City
Lyon
Country
France
Facility Name
Chu Marseille La Timone
City
Marseille
ZIP/Postal Code
13385
Country
France
Facility Name
Chu Marseille Nord
City
Marseille
ZIP/Postal Code
13385
Country
France
Facility Name
Chu Montpellier
City
Montpellier 5
ZIP/Postal Code
34295
Country
France
Facility Name
Chu Nancy
City
Nancy
ZIP/Postal Code
54035
Country
France
Facility Name
CHU de Nantes
City
Nantes
Country
France
Facility Name
CHU NICE
City
Nice
Country
France
Facility Name
Chu Nimes
City
Nîmes
Country
France
Facility Name
Ch Paris Beaujon
City
Paris
Country
France
Facility Name
Ch Paris Bichat
City
Paris
Country
France
Facility Name
Ch Paris Pitie Salpetriere
City
Paris
Country
France
Facility Name
Ch Paris Saint Antoine
City
Paris
Country
France
Facility Name
Ch Saint Louis-Lariboisiere
City
Paris
Country
France
Facility Name
Chu Poitiers
City
Poitiers
ZIP/Postal Code
86021
Country
France
Facility Name
Chu Rennes
City
Rennes
Country
France
Facility Name
Chu Rouen
City
Rouen
ZIP/Postal Code
76031
Country
France
Facility Name
Chu Saint Etienne
City
Saint Etienne
ZIP/Postal Code
42100
Country
France
Facility Name
Hopital Central Strasbourg
City
Strasbourg
ZIP/Postal Code
67098
Country
France
Facility Name
Hopital Hautepierre Strasbourg
City
Strasbourg
ZIP/Postal Code
67098
Country
France
Facility Name
Chu Toulouse
City
Toulouse 9
ZIP/Postal Code
31059
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29921685
Citation
Molliex S, Passot S, Futier E, Bonnefoi M, Rancon F, Lemanach Y, Pereira B. Stepped wedge cluster randomised controlled trial to assess the effectiveness of an optimisation strategy for general anaesthesia on postoperative morbidity and mortality in elderly patients (the OPTI-AGED study): a study protocol. BMJ Open. 2018 Jun 19;8(6):e021053. doi: 10.1136/bmjopen-2017-021053.
Results Reference
derived

Learn more about this trial

Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality

We'll reach out to this number within 24 hrs